Analyzing Growth Factors in Colorectal Cancer
Author Information
Author(s): M Landriscina, A Cassano, C Ratto, R Longo, M Ippoliti, B Palazzotti, F Crucitti, C Barone
Primary Institution: Catholic University, Rome, Italy
Hypothesis
The study investigates the role of basic fibroblast growth factor (bFGF) and vascular endothelial growth factor (VEGF) in the angiogenic phenotype of colorectal cancer.
Conclusion
The study found that while bFGF levels were lower in tumor tissues compared to healthy mucosa, VEGF levels were significantly higher in tumors and correlated with disease stage.
Supporting Evidence
- bFGF levels were significantly lower in tumor tissues compared to healthy mucosa.
- VEGF levels were significantly higher in tumors and correlated with the stage of disease.
- Both bFGF and VEGF were measured in tumor, peritumoral mucosa, and blood samples.
Takeaway
This study looked at two important growth factors in cancer and found that one is lower in tumors while the other is higher, which helps us understand how tumors grow.
Methodology
The study used enzyme-linked immunosorbent assay (ELISA) to measure bFGF and VEGF levels in tumor tissues, peritumoral mucosa, and blood samples from patients with colorectal cancer.
Limitations
The study did not characterize the specific cells involved in the production of bFGF and VEGF.
Participant Demographics
The study included 35 patients, composed of 20 men and 15 women, with a mean age of 62.7 years.
Statistical Information
P-Value
p<0.0000002 for bFGF and p<0.000003 for VEGF
Statistical Significance
p<0.05
Want to read the original?
Access the complete publication on the publisher's website